GSK sells anesthetics to Aspen for up to $370 million
 

GSK sells anesthetics to Aspen for up to $370 million
LONDON (Reuters) - GlaxoSmithKline is to sell its portfolio of anesthetic ***** to South Africa's Aspen Pharmacare for up to 280 million pounds ($372 million) as part of a drive by the British drugmaker to focus on core therapy areas.http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...KM:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...KM:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/Ss38f2gX5Y8